Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR2389) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Buramate
|
|||||
Synonyms |
Benzylurethane du glycol; Benzylurethane du glycol [French]; Buramat; Buramate; Buramate [USAN:INN]; Buramato; Buramato [INN-Spanish]; Buramatum; Buramatum [INN-Latin]; Hyamate; Q9HDA6U6V4; 2-Hydroxyethyl N-benzylcarbamate; 2-Hydroxyethyl benzylcarbamate; 242 HC; 4663-83-6; AC 601; AC-601; BRN 2838813; Benzylcarbamic acid 2-hydroxyethyl ester; CARBAMIC ACID, BENZYL-, 2-HYDROXYETHYL ESTER; Carbamic acid, (phenylmethyl)-, 2-hydroxyethyl ester; Ethylene glycol, mono(benzylcarbamate); NSC 30223; NSC30223; UNII-Q9HDA6U6V4
|
|||||
Indication | Focal seizure [ICD11: 8A68] | Phase 4 | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 195.21 | Topological Polar Surface Area | 58.6 | ||
Heavy Atom Count | 14 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
Cross-matching ID | ||||||
The Predicted Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Predicted Drug Metabolites (PDM) of This Drug | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.